Maria‐Cristina Sauerland

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

Klaus H. Metzeler, Manuela Hummel, Clara D. Bloomfield et al. · Blood · 2008 · 445 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

Thomas Büchner, Wolfgang E. Berdel, Claudia Haferlach et al. · Journal of Clinical Oncology · 2008 · 337 citations

Medicine, Oncology, Pharmacology +13

Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.

Thomas Büchner, Wolfgang Hiddemann, Bernhard Wörmann et al. · PubMed · 1999 · 321 citations

Medicine, Oncology, Pharmacology +17

Acute Myeloid Leukemia With Biallelic <i>CEBPA</i> Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome

Annika Dufour, Friederike Schneider, Klaus H. Metzeler et al. · Journal of Clinical Oncology · 2009 · 293 citations · Full text

Life Sciences, Genetics, Hematology +17

Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged Maintenance for Acute Myeloid Leukemia

Thomas Büchner, Wolfgang E. Berdel, Claudia Schoch et al. · Journal of Clinical Oncology · 2006 · 177 citations

Medicine, Oncology, Pharmacology +14